As more governments liberalize cannabis regulations, the mortality and morbidity impacts of this drug as well as its potential benefits when used for medicinal purposes will be of great interest to the insurance industry. This research presents statistics on marijuana use and the results of several studies on its effects.
Dementia is associated with growing old and has a devastating impact on individuals’ capacity to self-care. The organization Alzheimer’s Disease International projects there will be more than 75 million people with dementia worldwide by 2030.
This webcast will cover what we currently know about emerging global infectious diseases, reflecting on events from the 1918 Spanish flu to the current Ebola epidemic in West Africa. We will also discuss what tools are available to help the insurance industry better plan for and respond to tomorrow’s inevitable epidemics.
There are a number of health and lifestyle factors - obesity, smoking, air pollution - that are known to be risk factors for early mortality and receive considerable attention. New research has suggested that social connections should be added to this list, with a study finding loneliness and social isolation to be risk factors for all ages.
Researchers have suggested that patients with favorable intermediate-risk prostate cancer could be treated with active surveillance, similar to the way in which patients with low-risk prostate cancer currently can be.
In the United States, stroke was the fourth leading cause of death in 2013 and about 800,000 people are affected each year. In 2010, deaths due to ischemic strokes which can be attributed to high tobacco consumption accounted for more cases in Russia, China and India than in the rest of the world.
Dementia is a topic that is aired with increasing frequency in the media – perhaps due to raised awareness but certainly as a response to demographic change. The subject also arises in the context of life and health insurance product development, underwriting and claims.